by cognosadminteam | Jul 13, 2017 | News
13 JULY, 2017 Cognos Therapeutics plans to conduct a twenty-patient human clinical trial using direct delivery of Herceptin (a Genentech drug) to prove drug safety in the brain region. Cognos Therapeutics (Cognos Thx) plans to use Herceptin, a Genentech drug, to be...
by cognosadminteam | Sep 16, 2016 | News
Dr. Ali-Osman on future of cancer treatment 16 SEPT, 2016 Dr. Francis Ali-Osman Discusses Future of Cancer Treatment On September 16, 2016 Dr. Francis Ali-Osman was asked to speak at the Hancock Symposium at Westminster Collage on the state of cancer research and...
by cognosadminteam | Mar 28, 2015 | News
31 MAR, 2015 FDA’s Role In The Precision Medicine Initiative Pushes Combination Drug Devices to New Heights Sharing Cognos Therapeutics’ Vision. Most medical treatments are designed for the “average patient” as a “one-size-fits-all approach”,...
Recent Comments